This pharmaceutical MNC company is likely to announce Final Dividend of Rs 55 per equity share - know more details here!

With a PE ratio of 34.5x, the company trades at a discount compared to the industry PE of 50.1x. The company has ROCE of 16 per cent and ROE of 49.2 per cent.

Sanofi Consumer Healthcare India Ltd has announced the book closure dates for the payment of its final dividend for the financial year ending 31st December 2024. The company has recommended a final dividend of Rs 55 per equity share, each with a face value of Rs 10. This proposal awaits approval from the shareholders at the upcoming 2nd Annual General Meeting. The Register of Members and Share Transfer Books will be closed from 29th April 2025 to 5th May 2025, both days inclusive, to facilitate the dividend payment process. The record date for the dividend payment is set for 28th April 2025. 

Earlier, the company had received an order from the Tax Department upholding recovery of interest amounting to Rs 1.01 crore. 

In the Quarterly Results of December 2024, the company reported revenue of Rs 514.90 crore, compared to Rs 524.00 crore in September 2024 and Rs 469.20 crore in December 2023, showing a year-on-year growth of 9.74 per cent and a quarter-on-quarter decline of 1.74 per cent. The net profit for December 2024 stood at Rs 91.30 crore, higher than Rs 82.20 crore in September 2024 but lower than Rs 137.70 crore in December 2023, reflecting a year-on-year decline of 33.70 per cent and a quarter-on-quarter growth of 11.07 per cent. The net profit margin for the quarter was 17.73 per cent, compared to 15.69 per cent in the previous quarter and 29.35 per cent in the same quarter last year.

For the financial year 2024, the company recorded revenue of Rs 2,013.20 crore, a decline of 29.39 per cent from Rs 2,851.10 crore in financial year 2023. The net profit for FY24 was Rs 413.50 crore, compared to Rs 334.90 crore in FY23, marking a decline of 35.61 per cent. The net profit margin stood at 16.64 per cent for FY24, lower than 18.24 per cent recorded in the previous financial year.

Sanofi Consumer Healthcare India Limited, with a current stock market price of Rs. 5,430, has a market capitalisation of Rs 12,505 crores. The company's stock has experienced a 52-week high of Rs. 5499 and a low of Rs. 4360.3. Over the past year, the stock has provided 8.30 per cent returns in the last 1 year to its shareholders. The company operates within the healthcare sector, focusing on consumer healthcare products. 

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines. Sanofi Global and its 100% subsidiary - Hoechst GmbH, are the shareholders of Sanofi India and together hold 60.40%. Company's follows parent company's financial year hence, Financial year is same as Calender Year.

Sanofi India is among the top 3 pharmacetical multinational corporations. Company has a total portfolio of 32 brands serving 7 therapeutic areas. It has 5 brands in Top 300 in the Pharma Market. Its product has a reach in 28 Countries through 3000 distributors & 100,000 pharmacies.

With a PE ratio of 34.5x, the company trades at a discount compared to the industry PE of 50.1x. The company has ROCE of 16 per cent and ROE of 49.2 per cent. The company has dividend yield of 3.1 per cent.

Investors should keep an eye on this Small-Cap stock.

Disclaimer: The article is for informational purposes only and not investment advice.